Current Report Filing (8-k)
December 22 2017 - 9:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
December
19, 2017
Commission
File #:
000-53723
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
(State
or other jurisdiction of incorporation)
30-0791746
(IRS
Employer Identification Number)
555
Madison Avenue, 5
th
Floor
New
York, NY
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
39
Old Ridgebury Road
Danbury,
CT 06180
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Item 7.01
|
Completion of Acquisition or Disposition of Assets
|
On
December 19, 2017, Tauriga Sciences, Inc. (the “Company”) reached an agreement with E3 Consulting Inc., an Englewood,
CO based business (“E3”) to settle an existing Company balance sheet liability of $177,883.71 to E3 for a one-time
cash payment of $15,000 and a one-time issuance of 5,000,000 shares of Common Stock of the Company, which are restricted securities
as defined by the Securities Act of 1933, as amended. This liability dated back to a consulting agreement entered into by the
Company’s predecessor (Novo Energies Corp.) with E3 in 2010.
This
liability has been maintained in accounts payable on the Company’s balance sheet. Accordingly, as a result of the above-referenced
settlement, the Company expects that this liability will be removed from its balance sheet by or before December 31, 2017 (the
final date of its 3rd Fiscal Quarter of 2017).
The
press release announcing the settlement of the above-described liability is furnished as Exhibit 99.1 to this current report on
Form 8-K.
On
December 15, 2017, the Company engaged the national law firm of Nixon Peabody LLP in New York to provide legal services to the
Company in connection with its SEC filing obligations and securities related matters.
Item
9.01
|
|
Exhibits
Statements and Exhibits
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
December 22, 2017
|
TAURIGA
SCIENCES, INC.
|
|
|
|
|
By:
|
/s/
Seth M. Shaw
|
|
|
Seth
M. Shaw
|
|
|
Chief
Executive Officer
|
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Sep 2023 to Sep 2024